InvestorsHub Logo
Followers 1
Posts 43
Boards Moderated 0
Alias Born 08/17/2018

Re: ap17 post# 23619

Friday, 08/31/2018 2:49:35 PM

Friday, August 31, 2018 2:49:35 PM

Post# of 83074
As long as hemp doesn't decide to go after pharms core business. (i.e. traditional Rx, first line tx, etc.) the can peacefully coexist. The is a very clear(and huge) market space for CBD as long as they stay in their lane.

Furthermore, if CVSI as a company can stay financially solvent they are also an acquisition candidate. It cheaper for big pharm to buy them then it would be to compete against them starting from scratch.

Big pharms margins on OTC's and non-brand are not their bread and butter. For example, try finding a pharm rep selling Prozac these days. You can't because it doesn't make money. A thirty days supply will cost you $4 at Walmart - even without insurance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News